About this trial
The purpose of this trial is to determine the safety and efficacy of the drug lithium and the optimum dose when used with standard chemotherapy. It will also establish how well lithium works in combination with oxaliplatin and capecitabine to treat patients with advanced oesophago-gastric or colorectal cancer. The study will also be used to learn more about this drug and this type of cancer.
Patient Profile
Advanced oesophago-gastric or colorectal cancer
Where’s this trial being run?
Cork University Hospital and St James’s Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | Lithium |
|---|---|
| Number: | 11-32 |
| Full Title: | A Phase Ib, Dose Escalation Study of Lithium When Added to Standard Chemotherapy of Oxaliplatin and Capecitabine in Patients With Advanced Oesophago-Gastric or Colorectal Cancer. |
| Principal Investigator: | |
|---|---|
| Type: | In-House |
| Sponsor: | Cancer Trials Ireland |
| Recruitment Started: |
Global: Not applicable Ireland: Nov 2019 |
| Global Recruitment Target: | Not applicable |
|---|---|
| Ireland Recruitment Target: | 24 |